Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15061847rdf:typepubmed:Citationlld:pubmed
pubmed-article:15061847lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15061847lifeskim:mentionsumls-concept:C0007114lld:lifeskim
pubmed-article:15061847lifeskim:mentionsumls-concept:C0332835lld:lifeskim
pubmed-article:15061847lifeskim:mentionsumls-concept:C0021081lld:lifeskim
pubmed-article:15061847lifeskim:mentionsumls-concept:C0072980lld:lifeskim
pubmed-article:15061847lifeskim:mentionsumls-concept:C0205234lld:lifeskim
pubmed-article:15061847pubmed:issue4 Pt 2lld:pubmed
pubmed-article:15061847pubmed:dateCreated2004-4-5lld:pubmed
pubmed-article:15061847pubmed:abstractTextThe responsibility of immunosuppressants for the increased risk of skin cancers in organ transplant recipients is widely recognized. Discerning the role of each drug is complicated owing to the fact that most patients generally have combinations of several medications.lld:pubmed
pubmed-article:15061847pubmed:languageenglld:pubmed
pubmed-article:15061847pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15061847pubmed:citationSubsetIMlld:pubmed
pubmed-article:15061847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15061847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15061847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15061847pubmed:statusMEDLINElld:pubmed
pubmed-article:15061847pubmed:monthAprlld:pubmed
pubmed-article:15061847pubmed:issn1076-0512lld:pubmed
pubmed-article:15061847pubmed:authorpubmed-author:EuvrardSylvie...lld:pubmed
pubmed-article:15061847pubmed:authorpubmed-author:LefrancoisNic...lld:pubmed
pubmed-article:15061847pubmed:authorpubmed-author:UlrichClaasClld:pubmed
pubmed-article:15061847pubmed:issnTypePrintlld:pubmed
pubmed-article:15061847pubmed:volume30lld:pubmed
pubmed-article:15061847pubmed:ownerNLMlld:pubmed
pubmed-article:15061847pubmed:authorsCompleteYlld:pubmed
pubmed-article:15061847pubmed:pagination628-33lld:pubmed
pubmed-article:15061847pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:meshHeadingpubmed-meshheading:15061847...lld:pubmed
pubmed-article:15061847pubmed:year2004lld:pubmed
pubmed-article:15061847pubmed:articleTitleImmunosuppressants and skin cancer in transplant patients: focus on rapamycin.lld:pubmed
pubmed-article:15061847pubmed:affiliationDepartment of Dermatology, Edouard Herriott Hospital, Lyon, France. sylvie.euvrard@numericable.frlld:pubmed
pubmed-article:15061847pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15061847pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15061847lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15061847lld:pubmed